velaglucerase alfa (VPRIV)
velaglucerase alfa is an FDA-licensed reference biologic from Takeda Pharmaceuticals U.S.A., Inc.. Reference exclusivity, biosimilar lineage, and published patents from official FDA Purple Book records.
0
Biosimilars
0
Interchangeables
0
Listed patents
2010
Reference approved
Reference product
VPRIV velaglucerase alfa
Takeda Pharmaceuticals U.S.A., Inc.
- Approved
- Feb 26, 2010
- Marketing
- Rx
- Center
- CDER
- Patents
- None listed
Exclusivity & patent cliffs
Approval, exclusivity, and published-patent expiration dates for velaglucerase alfa, in chronological order.
Reference approval
Approval date of the reference velaglucerase alfa product.
16 yr 6 mo ago
Frequently asked questions
Are there biosimilars approved for velaglucerase alfa (VPRIV)?
No 351(k) biosimilars or interchangeable biosimilars referencing velaglucerase alfa are listed in the FDA Purple Book yet.
Explore the full FDA Purple Book
Search every FDA-licensed biologic, biosimilar, and interchangeable with exclusivity timelines and patent records.